Default company panoramic image

Gemmus Pharma Inc.

Repurposed drug for Influenza treatment

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded August 2007
  • Employees 5
  • Website

Company Summary

Gemmus Pharma Inc. is a privately held company incorporated in August 2007 to develop host-targeted treatments for moderate to life-threatening influenza infections. Gemmus' lead candidate was identified at a major pharmaceutical company and is a repurposed drug. Gemmus has submitted a pre-IND package to the FDA and has a defined development plan to obtain an IND.


  • Default avatar
    Daryl Faulds

    Dr. Faulds has over 20 years of experience in molecular biology, immunology and pharmaceutical development. Daryl has held a variety fo positions in both small and large pharmacutical and biotech companies and has lead projects in respiratory disease, autoimmune disease and basic research. Daryl received a BA in biology from UC San Diego and a PhD in molecular biology from the Univ of Oregon. He was an NIH postdoctoral fellow at UC Berkeley.

  • Default avatar
    William Guilford

    Dr. Guilford has over 20 years experience in medicinal chemistry at small and large pharmaceutical companis. Bill has held a variety of management positions on projects in the area of cardiovascular, inflammation and immunology. Bill received a BS in chemistry from UC Berkeley and a PhD in bioorganic chsmistry from the Univ of Illinois, Urbana/Champaign. He was an NIH postdoctoral fellow at ETH-Z, Zurich and a postdoctoral fellow at Harvard.

  • Default avatar
    William Holstein
    SVP Business Development

    Mr. Holstein has 17 years investment management experience ranging from real estate development to technology and biotechnology. As manager of a private investment portfolio in the San Francisco Bay Area, Bill has a wide range of experience and often takes an aactive role in assisting the portfolio companies. In addition to his management role at Gemmus, he is a minority shareholder. Bill earned his BA in Economics at UC Boulder.


  • Default avatar
    Bruce Jenett
    Default avatar
    Gale Bergado

Previous Investors

  • Default avatar
    Founders, Private Individual